|
|
|
Sunday, March 21, 2010 — 7:30 p.m.
|
- Breast Pathology Practice in the Era of Molecular and Personalized Therapy of Breast Cancer
|
|
Moderator:
|
Juan Palazzo, Jefferson University, Philadelphia, PA
|
| Biology-Driven Selection of Optimal Systemic Therapy for Primary Breast Cancer - Gabriel N. Hortobagyi, The University of Texas, MD Anderson Cancer Center, Houston, TX |
| Pathologic Response Following Neoadjuvant Chemotherapy as an Outcome for Clinical and Translational Research - W. Fraser Symmans, The University of Texas, MD Anderson Cancer Center, Houston, TX |
| Modern Classification of Breast Cancer-Should We Stick with Morphology or Convert to Molecular Profiles? - Ian O. Ellis, City Hospital NHS Trust, England |
|
|
|